Section Arrow
Quote
HBIO.NASDAQ
- Harvard Bioscience Inc.
Quotes are at least 15-min delayed:2026/05/19 07:05 EDT
Pre Market
Last
 5
0 (0.00%)
Bid
5
Ask
6.34
High 5 
Low 5 
Volume 17 
Regular Hours (Closed)
Last
 5
-0.25 (-4.76%)
Day High 
5.36 
Prev. Close
5.25 
1-M High
7.5 
Volume 
48.01K 
Bid
5
Ask
6.34
Day Low
4.9596 
Open
5.25 
1-M Low
5.25 
Market Cap 
23.68M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 6.25 
20-SMA 6.43 
50-SMA 5.67 
52-W High 9.458 
52-W Low 2.813 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-2.15/0.36
Enterprise Value
66.43M
Balance Sheet
Book Value Per Share
2.23
Cash Flow
Cash Flow Yield
0.13
Income Statement
Total Revenue
86.55M
Operating Revenue Per Share
24.95
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
AVTRAvantor7.6-0.02-0.26%-- 
Pre Market 7.56 -0.04 -0.53%
MDLNMedline Inc36.02-0.17-0.47%31.51PE
Pre Market 36.04 +0.02 +0.06%
BAXBaxter International17.79+0.49+2.83%-- 
Pre Market 17.79 0 0.00%
NVSTEnvista Holdings Corp23.15-0.07-0.30%56.46PE
Pre Market 23.08 -0.07 -0.30%
XRAYDENTSPLY SIRONA9.82-0.25-2.48%-- 
Pre Market 9.83 +0.01 +0.10%
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, products, and services that enable advances in life science applications, including research, drug and therapy discovery, bioproduction, and preclinical testing. The company organizes its product line into two product families: Cellular and Molecular Technologies (CMT) and Preclinical. The CMT product family supports molecular, cellular, organ, and organoid research, as well as bioproduction andin vitro testing, while the Preclinical product family provides products for preclinical research and testing, including data collection and analysis for safety and regulatory compliance. Its geographical segments include the Americas, Europe, Middle East and Africa, and Asia.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.